These studies suggest that the Caspase 3/GSDME pathway is highly significant in liver cancer, not only participating in the processes of apoptosis and pyroptosis but also potentially serving as a target for liver cancer treatment.
← all excerpts
CDC5L binds to ELAVL1 to inhibit pyroptosis in hepatocellular carcinoma through the Caspase 3/GSDME signaling pathway.
1
—
—